Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


Published ahead of print on July 11, 2007
J Am Soc Nephrol 18: 2320-2329, 2007
© 2007 American Society of Nephrology
doi: 10.1681/ASN.2006101093

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
ASN.2006101093v1
18/8/2320    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Davis, B.
Right arrow Articles by Gnudi, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Davis, B.
Right arrow Articles by Gnudi, L.
Related Collections
Right arrowRelated Article

BASIC RESEARCH

Podocyte-Specific Expression of Angiopoietin-2 Causes Proteinuria and Apoptosis of Glomerular Endothelia

Belinda Davis*, Alessandra Dei Cas*, David A. Long{dagger}, Kathryn E. White{ddagger}, Anthea Hayward*, Ching-Hsin Ku*, Adrian S. Woolf{dagger}, Rudolf Bilous{ddagger}, Giancarlo Viberti* and Luigi Gnudi*

* Cardiovascular Division, King's College London School of Medicine, Guy's Hospital, King's College London, and {dagger} Nephro-Urology Unit, Institute of Child Health, University College London, and {ddagger} Department of Diabetes and Metabolism, School of Clinical Medical Sciences, University of Newcastle, Newcastle, United Kingdom

Correspondence: Dr. Luigi Gnudi, Unit for Metabolic Medicine, Department of Diabetes and Endocrinology, 5th floor Thomas Guy House, Guy's Hospital, London SE1 9RT, UK. Phone: +44-20-71881939; Fax: +44-20-71880146; E-mail: luigi.gnudi{at}kcl.ac.uk

Received for publication October 6, 2006. Accepted for publication April 27, 2007.

Angiopoietin-2 (Ang-2) modulates embryonic vascular differentiation primarily by inhibiting the antiapoptotic effects of Ang-1 on endothelia that express the Tie-2 receptor. Ang-2 is transiently expressed by developing glomeruli but is downregulated with normal maturation. Glomerular Ang-2 expression is, however, markedly upregulated in animal models of diabetic nephropathy and glomerulonephritis, both leading causes of human chronic renal disease, affecting 10% of the world population. It was hypothesized that Ang-2 might have significant roles in the pathobiology of glomerular disease. Mice with inducible podocyte-specific Ang-2 overexpression were generated. When the transgene was induced in adults for up to 10 wk, mice had significant increases in both albuminuria and glomerular endothelial apoptosis, with significant decreases of both vascular endothelial growth factor-A and nephrin proteins, critical for maintenance of glomerular endothelia and filtration barrier functional integrity, respectively. There was, however, no significant change of systemic BP, creatinine clearance, or markers of renal fibrosis, and podocytes appeared structurally intact. In kidneys of young animals in which Ang-2 had been upregulated during organogenesis, increased apoptosis occurred in just-formed glomeruli. In vitro, short-term exposure of isolated wild-type murine glomeruli to exogenous Ang-2 led to decreased levels of vascular endothelial growth factor-A protein. These novel results provide insight into molecular mechanisms underlying proteinuric disorders, highlight potentially complex interactions between subsets of glomerular cells, and emphasize how a vascular growth factor that has critical roles in normal development may be harmful when re-expressed in the context of adult disease.


Related Article

Angiopoietin-2 and Glomerular Proteinuria
Mark P. de Caestecker
J. Am. Soc. Nephrol. 2007 18: 2217-2218. [Full Text] [PDF]



This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
W. Mu, D. A. Long, X. Ouyang, A. Agarwal, P. E. Cruz, C. A. Roncal, T. Nakagawa, X. Yu, W. W. Hauswirth, and R. J. Johnson
Angiostatin overexpression is associated with an improvement in chronic kidney injury by an anti-inflammatory mechanism
Am J Physiol Renal Physiol, January 1, 2009; 296(1): F145 - F152.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
C.-H. Ku, K. E. White, A. Dei Cas, A. Hayward, Z. Webster, R. Bilous, S. Marshall, G. Viberti, and L. Gnudi
Inducible Overexpression of sFlt-1 in Podocytes Ameliorates Glomerulopathy in Diabetic Mice
Diabetes, October 1, 2008; 57(10): 2824 - 2833.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
V. Campean, B. Karpe, C. Haas, A. Atalla, H. Peters, H. Rupprecht, S. Liebner, T. Acker, K. Plate, and K. Amann
Angiopoietin 1 and 2 gene and protein expression is differentially regulated in acute anti-Thy1.1 glomerulonephritis
Am J Physiol Renal Physiol, May 1, 2008; 294(5): F1174 - F1184.
[Abstract] [Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP